This HTML5 document contains 68 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37822178
rdf:type
wikibase:Item
schema:description
article scientifique scientific article published on 18 December 2010 articolo scientifico научни чланак bilimsel makale vetenskaplig artikel videnskabelig artikel vědecký článek vedecký článok article científic наукова стаття, опублікована в грудні 2010 artículu científicu espublizáu en 2010 wetenschappelijk artikel artigo científico مقالة علمية نشرت في 18 ديسمبر 2010 wissenschaftlicher Artikel
p:P577
wds:Q37822178-95C14A5B-447E-4541-A7F6-AE711993F142
wdt:P577
2010-12-18T00:00:00Z
p:P2093
wds:Q37822178-E90B7C91-4E70-449F-BE31-099A55212EC1 wds:Q37822178-48B0EDE4-C02E-4EEC-8306-5D31543695E3 wds:Q37822178-2EC66611-8A31-4FEF-8223-3729060F01D5 wds:Q37822178-300F835D-B937-44B2-9BF3-E66227141638 wds:Q37822178-1CC0B278-4996-4B31-94E0-8060F2509010
wdt:P2093
Rik J Scheper Alfons J M van den Eertwegh B Mary E von Blomberg Famke L Schneiders Henk M W Verheul
rdfs:label
Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection. Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection. Clinical experience with α-galactosylceramide
skos:prefLabel
Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection. Clinical experience with α-galactosylceramide Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection.
schema:name
Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection. Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection. Clinical experience with α-galactosylceramide
p:P50
wds:Q37822178-7B76BF60-81C6-45D8-A714-416B3375601F wds:Q37822178-84C58315-3E12-4785-92D7-43861021CD5B wds:Q37822178-385A530D-CA36-4AA6-B195-2EE2850C2E67 wds:Q37822178-EAF42EAC-4645-4BDE-9247-B7220E29769B
wdt:P50
wd:Q90913412 wd:Q114258610 wd:Q57051708 wd:Q114258632
p:P1476
wds:Q37822178-06AB36B4-9B52-4EAC-B264-58A6F2B99FFF
wdt:P1476
Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection
p:P304
wds:Q37822178-086D2492-B448-4977-8590-10A5FDB83E2A
wdt:P304
130-141
p:P31
wds:Q37822178-42E492BD-9A68-4E30-901D-BC9DE73B7D4B wds:Q37822178-f581c4fc-30a8-48cb-b213-cb6377eb80bd
wdt:P31
wd:Q7318358 wd:Q13442814
p:P921
wds:Q37822178-BA8648A6-4338-4F6B-A841-7D5F3637A031
wdt:P921
wd:Q62019625
p:P698
wds:Q37822178-9121B009-4B04-4670-8AEE-227E6538AA4F
wdtn:P698
n11:21169066
wdt:P698
21169066
p:P1433
wds:Q37822178-4ECBC08B-24C0-47AB-86B8-9600518AB8DE
wdt:P1433
wd:Q15752921
p:P433
wds:Q37822178-EC64CC29-2B2C-45D9-9B25-C93CE3666E07
p:P478
wds:Q37822178-47CF3032-B27C-48D8-A421-2123CDAB5543
wdt:P433
2
wdt:P478
140
p:P356
wds:Q37822178-AC1B0821-3CF5-47E7-B3AB-B98969E55CF8
wdtn:P356
n12:J.CLIM.2010.11.010
wdt:P356
10.1016/J.CLIM.2010.11.010